Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6026.5000 11.00 (0.18%)
NSE Sep 12, 2025 15:31 PM
Volume: 487.6K
 

6026.50
0.18%
Karvy
Divi's Lab Total revenues are up by 25.8% YoY to Rs 8.1 bn higher than our expectation of Rs 7.7 bn for the quarter. Operating margins stood at 37.1% lower than our estimate of 39.1% on account of lower gross margins due to product mix. Net Profit was up by 44.8% YoY to Rs 2,432 mn (higher than our estimates of Rs 2,123 mn) aided by higher other income and lower depreciation.
Divi's Laboratories .. has an average target of 6414.33 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended